About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Asthma Clinical Trials in Houston | 159 Studies

Clinical Trials AsthmaHouston

Asthma Clinical Trials in Houston

Find 159 clinical trials for asthma near Houston, Texas. Connect with research centers in your area.

All Asthma trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 159 trials

UnknownVibration Response Imaging (VRI) in Dyspnea Patients Presenting to the EDFor the patient with acute dyspnea in the ED, early differentiation between CHF and non-CHF causes is essential for proper management.NCT01206621·Newark, Delaware and 7 others Active not recruitingPreventing Asthma in High Risk KidsThis trial is a randomized, double-blind, placebo controlled trial designed to test whether two years treatment of preschool children aged 2-3 years of age at high risk for asthma…NCT02570984·Phoenix, Arizona and 12 others

Asthma Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With AsthmaThis is a Phase 3B, 12-week, multicenter, open-label study to evaluate the relationship between albuterol sulfate (ABS) eMDPI and clinical asthma exacerbation (CAE) in adult…NCT02969408·Litchfield Park, Arizona and 43 others

CompletedGSK BHR Study (Sont)The purpose of this study was to determine whether asthma control and reduced bronchial hyperresponsiveness could be achieved and maintained at a lower dose of inhaled…NCT00920543·Birmingham, Alabama and 57 others

RecruitingIndividualizing Treatment for Asthma in Primary Care (Full Study)While asthma therapy is becoming more individualized based on asthma phenotypes, more research is needed to tailor newer therapies to individuals.NCT07052942·Aurora, Colorado and 12 others

CompletedCombivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe AsthmaThe purpose of this study is to demonstrate the superior bronchodilator efficacy of inhaled Combivent® CFC MDI vs. Albuterol HFA MDI in moderate to severe asthma patients.NCT00096616·Birmingham, Alabama and 26 others

CompletedStudy of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.This study aimed to determine the efficacy and safety of QAW039 and QAW039 450 mg compared to placebo, when added to GINA (Global Initiative for Asthma) steps 4 and 5 standard-of-…NCT02563067·Little Rock, Arkansas and 162 others

CompletedEvaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and AdolescentsA randomised, double-blind, double-dummy, placebo controlled (with rescue medication), multicenter study to evaluate the efficacy and safety of Fluticasone Furoate inhalation…NCT01159912·Birmingham, Alabama and 81 others

Active not recruitingStudy of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk AsthmaThis is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.NCT06676319·Saraland, Alabama and 220 others

TerminatedSafety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease ModificationThis study consists of a 3-year double-blind phase during which patients will receive atopic dermatitis (AD) treatment either with pimecrolimus cream 1% long-term management (LTM)…NCT00124709·Birmingham, Alabama and 35 others

CompletedStudy Of Allergic Rhinitis In Patients Who Also Have AsthmaThis study will last up to 6 weeks. Subjects will visit the clinic up to 5 times.NCT00296491·Birmingham, Alabama and 120 others

CompletedEfficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant AsthmaStudy Comparing the Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistent AsthmaNCT03358147·Birmingham, Alabama and 231 others

CompletedA 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With AsthmaThis purpose of this study is to show the superiority and long term safety and efficacy of adding a long acting beta agonist (salmeterol) to constant dose of an inhaled…NCT00452348·Birmingham, Alabama and 80 others

CompletedA Comparison of SYMBICORT® pMDI With Budesonide HFA pMDI in African American Subjects With Asthma.The purpose of this study is to determine the effectiveness and safety of SYMBICORT® pMDI (a medication approved by the Food and Drug Administration, FDA) in the African American…NCT00419952·Birmingham, Alabama and 121 others

CompletedA Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma MedicationsThe primary objective of this study is to evaluate the dose response, efficacy and safety of 4 different doses of fluticasone propionate (50, 100, 200, and 400mcg) delivered as…NCT01576718·Birmingham, Alabama and 299 others

CompletedStudy in Patients With AsthmaThe purpose of this study is to determine the most safe and effective dose of the investigational drug in comparison with a control drug and placebo.NCT00215410·Little Rock, Arkansas and 11 others

CompletedOpen Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation.The primary objective of this study is to assess the immunogenic potential of the liquid formulation of omalizumab administered over a period of 6 months in moderate to severe…NCT00500539·Scottsdale, Arizona and 30 others

CompletedSafety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma Subjects > or = 12 Years of AgeThe primary objective of this study is to evaluate the efficacy and safety of adding GSK2190915 100mg, GSK2190915 300mg or placebo tablets administered once daily to fluticasone…NCT01156792·Birmingham, Alabama and 31 others

CompletedDiagnosing Respiratory Disease in Children Using Cough Sounds 2The purpose of this prospective study is to evaluate the efficacy of the ResAppDx software application in the diagnosis of childhood acute respiratory disease, including…NCT03392363·Boston, Massachusetts and 2 others

CompletedSafety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux AsthmaThe purpose of this study is to determine whether treatment with esomeprazole for 6 months will improve asthma in adult patients with moderate to severe asthma and symptoms of…NCT00317044·Birmingham, Alabama and 129 others

PreviousPage 3 of 8Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia